News
Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.
12h
Barchart on MSNWeightWatchers Has Exited Bankruptcy. How Should You Play WW Stock Here?Many health and wellness stocks have faced challenges in recent years as GLP-1 weight-loss drugs like Ozempic and Wegovy ...
TOKYO-Nintendo's new Switch 2 videogame machine uses a rare-earth magnet to attach its hand-held controllers to the main console, according to a teardown, highlighting the company's vulnerability to ...
11h
Zacks Investment Research on MSNCan Mounjaro and Zepbound Drive Another Strong Quarter for Eli Lilly?Mounjaro (for type II diabetes) and Zepbound (for obesity) — remains strong. Despite being on the market for less than three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results